This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Hyperhidrosis
R18_HYPERHIDROSIS
hypohidrosis: diminished sweating in response to appropriate stimuli. While hyperhidrosis is a socially troubling but benign condition, hypohidrosis can lead to hyperthermia, heat exhaustion, heat stroke and potentially death.[1] An extreme case of hypohydrosis in which there is a complete absence of sweating and the skin is dry is termedanhidrosis.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1239 |
4. Check minimum number of eventsNone |
1239 |
5. Include endpointsNone |
1239 |
6. Filter based on genotype QC (FinnGen only) |
1239 |
Control definitions (FinnGen only)
- Control exclude
- R18_GENERAL_SYMPTOMS_SIGNS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R[5-6]
- Name in latin
- Hyperhidrosis
Similar endpoints
↥List of similar endpoints to
Hyperhidrosis
based on the number of shared cases.
Similar with more cases:
- General symptoms and signs
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1239 | 927 | 312 |
| Unadjusted period prevalence (%) | 0.27 | 0.32 | 0.14 |
| Median age at first event (years) | 42.32 | 41.07 | 46.04 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1103
- Matched controls
- 11028
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R61.9
ICD-10 Finland
Hyperhidrosis, unspecified
581.7
323.0
553
19
R61.0
ICD-10 Finland
Localized hyperhidrosis
4603.1
323.0
468
*
R61.1
ICD-10 Finland
Generalized hyperhidrosis
2372.7
198.0
186
*
R61
ICD-10 Finland
Hyperhidrosis
112.9
136.9
147
15
R51.80
ICD-10 Finland
Headache
8.5
90.4
212
299
G04BD04
ATC
oxybutynin; oral, transdermal
11.4
82.7
162
164
M03AX01
ATC
botulinum toxin; parenteral
40.4
81.8
103
28
N03AX16
ATC
pregabalin; oral
3.9
67.4
329
1072
N06AX16
ATC
venlafaxine; oral
4.2
61.7
268
777
A09
ICPC
Sweating problem
35.0
51.0
66
20
R53
ICD-10 Finland
Malaise and fatigue
3.7
50.5
255
829
N06AX11
ATC
mirtazapine; oral
2.8
48.2
412
1935
N05BA04
ATC
oxazepam; oral
3.0
47.6
346
1465
N03AX12
ATC
gabapentin; oral
3.8
45.3
213
647
R55
ICD-10 Finland
Syncope and collapse
16.7
44.5
72
46
R50.9
ICD-10 Finland
Fever, unspecified
5.4
40.8
129
262
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.8
40.7
312
1342
N06AB04
ATC
citalopram; systemic
3.0
40.7
287
1171
N05AH04
ATC
quetiapine; oral
3.2
40.2
249
930
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.6
39.2
145
349
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.4
39.1
454
2464
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
38.6
417
2176
N05CF01
ATC
zopiclone; oral
2.6
38.3
359
1731
N02AX02
ATC
tramadol; systemic, rectal
2.4
38.0
434
2323
N06AX21
ATC
duloxetine; oral
3.9
37.8
169
486
C07AA05
ATC
propranolol; systemic
2.8
37.6
293
1265
QBZ00
NOMESCO Finland
Botulin injections for hyperhidrosis of axilla
+∞
35.6
34
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
98.3
34.9
38
*
A06AC01
ATC
ispaghula (psylla seeds); oral
2.7
34.3
283
1255
A02BC02
ATC
pantoprazole; systemic
2.2
33.8
664
4513
M54.5
ICD-10 Finland
Low back pain
2.3
33.4
392
2098
3AX01
NOMESCO Finland
NA
87.7
30.9
34
*
C07AB07
ATC
bisoprolol; oral
2.2
30.8
408
2293
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
7.2
30.3
75
110
M03BX02
ATC
tizanidine; oral
2.1
30.2
689
4880
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.1
29.9
187
691
R06.0
ICD-10 Finland
Dyspnoea
2.6
29.8
260
1177
A02BC03
ATC
lansoprazole; oral
2.4
29.6
311
1553
A02BC05
ATC
esomeprazole; systemic
2.2
29.5
426
2476
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.1
29.4
503
3142
H02AB06
ATC
prednisolone; systemic
2.1
29.3
482
2964
A02BC01
ATC
omeprazole; systemic
2.4
28.5
296
1466
J02AC01
ATC
fluconazole; systemic
2.1
28.3
514
3279
UJF32
NOMESCO Finland
Coloscopy
2.5
27.9
257
1195
L03
ICPC
Low back symptom/complaint
2.4
27.8
298
1497
N06AB10
ATC
escitalopram; oral
2.4
27.5
292
1458
N02BE01
ATC
paracetamol; systemic, rectal
2.3
27.2
915
7466
M25.5
ICD-10 Finland
Pain in joint
2.2
26.2
333
1804
R07.4
ICD-10 Finland
Chest pain, unspecified
2.4
26.0
251
1190
N05BA01
ATC
diazepam; systemic, rectal
3.1
25.7
155
555
AA1AD
NOMESCO Finland
CT of head and brain
2.7
25.6
193
797
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
25.5
309
1636
SPAT1263
SPAT
Sampling
2.0
24.4
502
3295
N06AA09
ATC
amitriptyline; systemic
3.5
24.3
121
376
N06AB06
ATC
sertraline; oral
2.9
24.3
162
617
J01AA02
ATC
doxycycline; systemic
2.0
24.2
801
6271
N03AE01
ATC
clonazepam; systemic
4.9
24.1
81
175
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.8
23.8
168
665
R60.0
ICD-10 Finland
Localized oedema
4.4
23.8
90
220
ADA20
NOMESCO Finland
Thoracal sympathectomy
127.8
23.7
25
*
N06AB05
ATC
paroxetine; oral
3.9
23.2
100
276
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.8
22.9
100
279
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.6
22.8
110
333
N06AX12
ATC
bupropion; oral
3.5
22.8
113
350
M79.7
ICD-10 Finland
Fibromyalgia
6.1
22.7
63
109
N02AJ06
ATC
codeine and paracetamol; systemic
2.0
22.6
409
2535
R03AC02
ATC
salbutamol; inhalant
1.9
22.6
590
4183
G47.3
ICD-10 Finland
Sleep apnoea
2.5
22.5
200
903
J01DB01
ATC
cefalexin; oral
2.1
22.5
895
7404
A02BA02
ATC
ranitidine; systemic
2.5
22.3
194
864
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
22.1
234
1153
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.2
21.8
122
412
M54.2
ICD-10 Finland
Cervicalgia
3.7
21.3
98
285
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.3
21.2
217
1048
M70.6
ICD-10 Finland
Trochanteric bursitis
2.9
21.1
138
519
P06
ICPC
Sleep disturbance
2.8
21.1
145
563
ZX114
NOMESCO Finland
Intramuscular
11.2
20.8
39
36
N05CF02
ATC
zolpidem; oral
2.4
20.7
201
946
UKC02
NOMESCO Finland
Cystoscopy
2.9
20.5
135
510
SPAT1310
SPAT
Counselling related to known health issue
1.9
20.1
376
2340
M01AB05
ATC
diclofenac; systemic, rectal
1.8
20.0
684
5218
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.8
19.8
135
521
L02
ICPC
Back symptom/complaint
2.9
19.8
128
478
A06AD11
ATC
lactulose; oral
3.0
19.7
122
442
J01MA02
ATC
ciprofloxacin; systemic
1.9
19.6
367
2278
R42
ICD-10 Finland
Dizziness and giddiness
2.3
19.6
203
985
M79.6
ICD-10 Finland
Pain in limb
1.9
19.5
360
2220
R01AD09
ATC
mometasone; nasal
1.8
19.1
510
3569
H03AA01
ATC
levothyroxine sodium; systemic
2.1
19.0
269
1497
M01AH05
ATC
etoricoxib; oral
1.8
18.8
601
4442
TQW70
NOMESCO Finland
Iontoferesis therapy
+∞
18.8
18
*
N02AA05
ATC
oxycodone; systemic
3.0
18.7
112
397
SPAT1153
SPAT
Removal of sutures
2.0
18.7
308
1816
R07.3
ICD-10 Finland
Other chest pain
3.2
18.6
104
350
A02BC04
ATC
rabeprazole; oral
3.0
18.6
112
399
N03AX09
ATC
lamotrigine; oral
4.1
18.4
73
187
R63.4
ICD-10 Finland
Abnormal weight loss
7.8
18.3
42
56
M01AE03
ATC
ketoprofen; systemic, rectal
1.9
18.3
359
2255
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.1
18.2
240
1293
N06AG02
ATC
moclobemide; oral
4.5
18.2
66
155
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.8
18.1
78
215
F51.0
ICD-10 Finland
Nonorganic insomnia
2.4
18.1
171
792
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
3.0
18.0
109
389
M79.1
ICD-10 Finland
Myalgia
2.5
18.0
155
683
N06AB03
ATC
fluoxetine; oral
2.5
17.9
148
635
G44.2
ICD-10 Finland
Tension-type headache
2.5
17.9
156
690
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.7
17.8
130
521
R52.9
ICD-10 Finland
Pain, unspecified
3.4
17.8
90
283
SPAT1240
SPAT
Therapeutic discussion
2.4
17.8
163
741
E0000UV
ATC
NA
1.8
17.7
445
3029
J01FF01
ATC
clindamycin; systemic
2.0
17.5
275
1586
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.6
17.5
140
590
M01AE02
ATC
naproxen; oral, rectal
1.7
17.1
629
4791
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.3
17.1
87
275
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.0
17.1
103
367
D01
ICPC
Abdominal pain/cramps general
2.4
17.1
154
694
M79.0
ICD-10 Finland
Rheumatism, unspecified
5.1
17.1
54
110
QBE05
NOMESCO Finland
Excision of sweat glands or sweat gland bearing skin from trunk
50.8
17.0
20
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
17.0
271
1569
P01AB01
ATC
metronidazole; oral, rectal
1.8
17.0
416
2799
QXZ00
NOMESCO Finland
Botulin injections for hyperhidrosis of unspecified localisation
+∞
16.7
16
*
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.6
16.7
129
533
K07.60
ICD-10 Finland
Snapping jaw
3.4
16.7
83
258
D07AC01
ATC
betamethasone; topical
1.8
16.7
345
2192
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.8
16.5
113
436
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
16.5
443
3057
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
16.5
272
1595
R06AX27
ATC
desloratadine; oral
1.8
16.4
344
2193
A03FA02
ATC
cisapride; oral, rectal
3.2
16.3
87
285
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
16.2
533
3905
L01
ICPC
Neck symptom/complaint
2.3
16.1
164
783
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
15.9
279
1666
A01
ICPC
Pain general/multiple sites
3.1
15.8
89
301
R13
ICD-10 Finland
Dysphagia
3.7
15.8
70
198
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.8
15.7
104
394
M54.4
ICD-10 Finland
Lumbago with sciatica
2.2
15.6
179
902
C03CA01
ATC
furosemide; systemic
2.2
15.5
182
926
S18
ICPC
Laceration/cut
1.8
15.5
389
2614
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.8
15.4
102
385
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.1
15.4
203
1085
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
15.4
136
605
H04.10
ICD-10 Finland
Dry eye syndrome
2.7
15.4
109
429
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.6
15.3
119
495
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
4.7
15.3
52
115
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
15.3
328
2097
R01AD08
ATC
fluticasone; nasal
1.8
15.3
312
1962
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.5
15.2
124
529
R03BA05
ATC
fluticasone; inhalant
2.0
15.2
205
1107
N06AA06
ATC
trimipramine; systemic
6.2
15.1
40
66
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.8
15.1
65
180
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
14.9
184
955
TQW99
NOMESCO Finland
Other minor procedure on skin
4.0
14.9
60
157
N05BA12
ATC
alprazolam; oral
2.6
14.8
113
465
R51
ICD-10 Finland
Headache
3.7
14.6
64
180
L17
ICPC
Foot/toe symptom/complaint
1.9
14.5
247
1458
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.7
14.5
101
395
R52.2
ICD-10 Finland
Other chronic pain
6.5
14.4
37
59
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.6
14.3
520
3870
M01AH01
ATC
celecoxib; oral (coxibs)
2.1
14.2
167
851
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.9
14.0
86
310
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
14.0
182
967
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.2
14.0
75
247
G04BD08
ATC
solifenacin; oral
3.4
14.0
67
203
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.3
14.0
130
595
R00.2
ICD-10 Finland
Palpitations
2.9
13.8
85
307
SPAT1301
SPAT
No procedures
1.8
13.8
317
2057
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.9
13.8
88
324
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
13.8
547
4148
SPAT1229
SPAT
Assessment of need for aid
3.2
13.7
73
239
R4110
NOMESCO Finland
Physiotherapy
1.9
13.7
247
1482
J01FA09
ATC
clarithromycin; systemic
1.7
13.6
346
2314
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.1
13.6
165
849
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.8
13.6
88
328
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
4.0
13.6
54
140
J01FA10
ATC
azithromycin; systemic
1.6
13.5
659
5266
A04
ICPC
Weakness/tiredness general
2.2
13.4
140
674
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.2
13.4
144
702
F45.8
ICD-10 Finland
Other somatoform disorders
2.5
13.4
106
443
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.4
13.3
66
205
XQ800
NOMESCO Finland
Prick test
2.5
13.2
108
460
M03BC51
ATC
orphenadrine, combinations; systemic
1.8
13.2
287
1829
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
13.2
439
3166
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.8
13.1
247
1501
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
4.5
13.1
46
106
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.3
13.1
131
620
M03BC01
ATC
orphenadrine (citrate); systemic
1.8
13.1
245
1486
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
3.0
13.1
75
259
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
13.0
332
2219
P03
ICPC
Feeling depressed
2.2
13.0
135
649
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.9
13.0
79
283
L15
ICPC
Knee symptom/complaint
1.9
12.8
198
1123
C05AA08
ATC
fluocortolone; rectal, topical
2.2
12.7
140
693
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
12.7
412
2943
S29
ICPC
Skin symptom/complaint other
2.0
12.6
166
883
R02
ICPC
Shortness of breath/dyspnoea
2.3
12.6
116
526
P01
ICPC
Feeling anxious/nervous/tense
2.1
12.6
160
840
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
12.6
168
901
N04BC05
ATC
pramipexole; oral
3.1
12.6
71
241
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.2
12.6
139
688
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.3
12.5
115
523
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
8.1
12.4
27
34
R96
ICPC
Asthma
2.6
12.3
91
367
G04BD12
ATC
mirabegron; oral
2.7
12.3
83
317
SPAT1216
SPAT
Assessment of functional ability
2.2
12.2
130
632
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
2.2
12.2
134
660
C09CA06
ATC
candesartan; oral
1.9
12.2
192
1096
R06AX22
ATC
ebastine; oral
1.9
12.2
202
1173
SPAT1254
SPAT
Administration of medicine
2.1
12.2
143
728
R60.9
ICD-10 Finland
Oedema, unspecified
4.6
12.1
41
91
P76
ICPC
Depressive disorder
2.6
12.1
91
372
R11
ICD-10 Finland
Nausea and vomiting
2.7
12.1
83
321
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.4
12.1
59
182
N06AX26
ATC
vortioxetine; oral
2.8
12.0
79
298
UJF30
NOMESCO Finland
Ileoscopy through colon
2.5
11.9
95
401
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.7
11.9
79
301
D07AD01
ATC
clobetasol; topical
2.0
11.9
153
808
H02AB07
ATC
prednisone; oral
2.2
11.8
130
642
R06AE07
ATC
cetirizine; oral
1.6
11.8
479
3603
L13
ICPC
Hip symptom/complaint
2.1
11.8
142
727
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
11.8
375
2652
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.1
11.7
141
721
G04CA02
ATC
tamsulosin; oral
2.3
11.7
117
552
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.1
11.7
141
724
R35
ICD-10 Finland
Polyuria
3.5
11.6
53
155
SPAT1312
SPAT
General health counselling
1.6
11.6
360
2529
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
11.6
162
884
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.2
11.5
61
200
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.8
11.5
75
280
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.8
11.5
210
1259
M48.0
ICD-10 Finland
Spinal stenosis
2.5
11.5
92
389
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.8
11.5
72
265
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.6
11.4
86
352
H02AB04
ATC
methylprednisolone; systemic
2.1
11.3
134
680
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.4
11.2
96
420
EMB10
NOMESCO Finland
Tonsillectomy
2.4
11.1
96
422
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
20.3
11.1
16
8
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.4
11.1
53
161
A07AA02
ATC
nystatin; oral
3.1
11.1
60
200
R01AD12
ATC
fluticasone furoate; nasal
1.6
11.1
337
2345
R01BA52
ATC
pseudoephedrine, combinations; oral
1.7
11.0
293
1964
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.2
11.0
110
520
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
11.0
332
2308
P20
ICPC
Memory disturbance
2.6
11.0
80
322
N05BE01
ATC
buspirone; oral
4.4
10.9
39
92
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.4
10.9
52
158
XF402
NOMESCO Finland
ECG with work load test
2.5
10.9
85
354
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
10.9
558
4411
R05
ICPC
Cough
1.7
10.9
234
1476
N05AA02
ATC
levomepromazine; systemic
4.0
10.8
42
108
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.5
10.8
82
338
L16
ICPC
Ankle symptom/complaint
2.2
10.7
113
546
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.6
10.7
48
139
R12
ICD-10 Finland
Heartburn
2.5
10.7
82
339
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
10.7
243
1557
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
10.7
119
590
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.6
10.7
75
296
C07AB02
ATC
metoprolol; systemic
2.0
10.6
149
810
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
10.6
149
811
R05
ICD-10 Finland
Cough
1.8
10.6
181
1058
J01FA06
ATC
roxithromycin; oral
1.6
10.6
384
2789
G43.9
ICD-10 Finland
Migraine, unspecified
2.7
10.6
73
283
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.3
10.6
53
168
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.8
10.5
67
249
N01
ICPC
Headache
2.0
10.5
137
726
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.1
10.5
40
101
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
10.5
389
2843
J35.0
ICD-10 Finland
Chronic tonsillitis
2.4
10.4
86
370
A03CA02
ATC
clidinium and psycholeptics; oral
3.2
10.4
54
176
A03FA01
ATC
metoclopramide; systemic, rectal
1.8
10.4
184
1090
N06AX03
ATC
mianserin; oral
3.5
10.3
47
138
N05CD07
ATC
temazepam; oral
2.4
10.3
91
405
M01AX01
ATC
nabumetone; oral
3.6
10.3
46
133
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.8
10.2
205
1261
Z71.8
ICD-10 Finland
Other specified counselling
1.7
10.1
258
1706
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
10.1
163
934
TAB00
NOMESCO Finland
Lumbar puncture
3.4
10.0
48
147
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
10.2
10.0
19
19
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
10.0
162
928
N03AG01
ATC
valproic acid; systemic, rectal
3.0
10.0
57
197
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
10.0
422
3168
XKD00
NOMESCO Finland
Uroflowmetry
2.3
9.9
93
427
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.8
9.8
62
229
M01AC06
ATC
meloxicam; systemic, rectal
1.6
9.8
319
2246
C08CA13
ATC
lercanidipine; oral
2.3
9.8
92
420
N03AF01
ATC
carbamazepine; oral, rectal
3.5
9.8
45
134
D11
ICPC
Diarrhoea
1.9
9.7
137
748
A05
ICPC
Feeling ill
2.3
9.7
86
383
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.5
9.7
384
2836
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.5
9.7
78
332
R03BA01
ATC
beclometasone; inhalant
2.0
9.6
134
726
J01CA04
ATC
amoxicillin; systemic
1.6
9.6
876
7787
L08
ICPC
Shoulder symptom/complaint
1.8
9.6
163
950
R74
ICPC
Upper respiratory infection acute
1.6
9.6
341
2453
R01AD01
ATC
beclometasone; nasal
1.9
9.6
157
904
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
9.5
285
1962
R06.5
ICD-10 Finland
Mouth breathing
2.4
9.5
83
369
L09
ICPC
Arm symptom/complaint
3.1
9.5
50
165
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
9.5
713
6049
L28
ICPC
Limited function/disability (L)
2.1
9.5
115
592
J01CA08
ATC
pivmecillinam; oral
1.5
9.5
440
3366
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.0
9.4
131
712
D12
ICPC
Constipation
4.1
9.4
35
87
J01DA01
ATC
[U] cefalexin; systemic
1.5
9.4
621
5120
N06AX05
ATC
trazodone; oral
4.3
9.3
33
78
J01AA07
ATC
tetracycline; systemic
1.8
9.3
180
1094
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
2.4
9.3
78
337
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
3.4
9.3
43
129
WX002
NOMESCO Finland
Sedation and analgesia
1.8
9.3
160
939
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.6
9.2
40
114
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.9
9.2
129
704
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.0
9.1
122
651
N30.0
ICD-10 Finland
Acute cystitis
1.9
9.1
139
781
NF1AA
NOMESCO Finland
Hip X-ray examination
2.5
9.1
68
278
R19.4
ICD-10 Finland
Change in bowel habit
4.3
9.0
32
76
J01MA12
ATC
levofloxacin; systemic
1.9
9.0
137
768
M50.3
ICD-10 Finland
Other cervical disc degeneration
4.9
9.0
28
58
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.8
9.0
166
996
L70.0
ICD-10 Finland
Acne vulgaris
2.9
9.0
52
183
K59.0
ICD-10 Finland
Constipation
3.0
8.9
51
176
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
8.9
295
2077
M01AE01
ATC
ibuprofen; systemic, rectal
1.7
8.9
957
8753
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
8.9
239
1597
ELB40
NOMESCO Finland
Partial parotidectomy
8.0
8.9
19
24
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.9
8.8
53
191
L29.9
ICD-10 Finland
Pruritus, unspecified
4.2
8.8
32
78
SPAT1262
SPAT
Handing over of treatment supplies
1.8
8.8
144
829
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.3
8.8
78
350
M54
ICD-10 Finland
Dorsalgia
2.0
8.7
118
634
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.8
8.7
55
203
A10BA02
ATC
metformin; oral
1.7
8.7
197
1254
J02AC02
ATC
itraconazole; systemic
1.8
8.7
173
1058
K30
ICD-10 Finland
Functional dyspepsia
2.1
8.7
101
510
SPAT1097
SPAT
Recording of ECG
2.0
8.7
117
627
M02AA10
ATC
ketoprofen; topical
1.9
8.7
141
809
WX290
NOMESCO Finland
Other blockade of nerve
1.5
8.7
484
3826
N06AB08
ATC
fluvoxamine; oral
4.1
8.6
32
80
R51.81
ICD-10 Finland
Facial pain NOS
7.0
8.6
20
29
Z01.2
ICD-10 Finland
Dental examination
1.5
8.5
435
3370
P74
ICPC
Anxiety disorder/anxiety state
2.7
8.5
56
214
M47.82
ICD-10 Finland
Other spondylosis, cervical region
3.4
8.5
40
122
K59.1
ICD-10 Finland
Functional diarrhoea
2.9
8.5
50
178
F40.1
ICD-10 Finland
Social phobias
3.2
8.5
42
133
R05FA02
ATC
opium derivatives and expectorants; systemic
1.5
8.5
391
2965
P29
ICPC
Psychological sympt/compl other
2.3
8.5
74
330
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
4.4
8.5
29
67
A03BA03
ATC
hyoscyamine; oral
7.4
8.5
19
26
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.8
8.5
51
185
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.5
8.5
65
271
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
4.7
8.5
27
58
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
4.4
8.3
29
68
QCZ00
NOMESCO Finland
Botulin injections for hyperhidrosis of hands
+∞
8.3
8
*
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.2
8.3
85
406
C01DA14
ATC
isosorbide mononitrate; oral
2.2
8.3
82
384
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.7
8.3
35
98
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.7
8.3
34
93
DHB50
NOMESCO Finland
Turbinoplasty
3.7
8.3
34
93
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.4
8.3
70
307
G54.0
ICD-10 Finland
Brachial plexus disorders
4.5
8.3
28
64
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
4.5
8.3
28
64
A02BA03
ATC
famotidine; systemic
3.4
8.3
38
114
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.5
8.2
63
261
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.8
8.2
146
861
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
8.2
315
2290
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.5
8.2
64
269
J05AB01
ATC
aciclovir; systemic
1.6
8.2
211
1389
J20
ICD-10 Finland
Acute bronchitis
2.1
8.2
95
478
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
8.2
162
992
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.5
8.2
62
255
A02BA04
ATC
nizatidine; systemic
2.6
8.2
59
237
Z00.0
ICD-10 Finland
General medical examination
1.7
8.1
176
1107
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
8.1
115
629
JAH01
NOMESCO Finland
Laparoscopy
2.7
8.1
52
196
N05BA06
ATC
lorazepam; systemic, sublingual
3.1
8.1
43
144
R68.88
ICD-10 Finland
Other specified general symptoms and signs, not elsewhere classified.
33.6
8.1
10
*
M01AX17
ATC
nimesulide; oral
1.7
8.1
186
1188
N06AA12
ATC
doxepin; systemic
3.0
8.0
46
160
SPAT1307
SPAT
Psychosocial counselling and guidance
2.1
8.0
90
449
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.0
8.0
106
563
F34.1
ICD-10 Finland
Dysthymia
2.8
7.9
48
175
J31.0
ICD-10 Finland
Chronic rhinitis
2.2
7.9
77
359
H01
ICPC
Ear pain/earache
1.9
7.9
124
701
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.8
7.9
136
794
SPAT1211
SPAT
Application of soft bandage
2.1
7.9
86
423
XF404
NOMESCO Finland
Ambulatory ECG
2.4
7.9
66
286
M54.1
ICD-10 Finland
Radiculopathy
3.2
7.8
39
125
R05FB02
ATC
cough suppressants and expectorants
1.5
7.8
319
2348
E000001
ATC
NA
1.6
7.8
213
1426
SPAT1212
SPAT
Extensive examination of musculoskeletal system
2.1
7.8
82
399
R03DC03
ATC
montelukast; oral
1.7
7.8
160
987
N06AA10
ATC
nortriptyline; systemic
4.9
7.8
24
50
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
3.2
7.8
38
120
SPAT1260
SPAT
Consultation of another employee
1.7
7.7
169
1063
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.1
7.7
88
443
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.9
7.7
117
654
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
4.0
7.7
29
74
G03FA01
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
1.9
7.7
115
640
XQ802
NOMESCO Finland
Epicutan test
2.7
7.7
51
197
R21
ICPC
Throat symptom/complaint
1.6
7.7
250
1746
N05AX08
ATC
risperidone; systemic
2.4
7.7
63
273
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.9
7.7
111
611
J04.0
ICD-10 Finland
Acute laryngitis
2.9
7.7
45
161
E66.01
ICD-10 Finland
Obesity due to excess calories
2.1
7.6
83
410
F32
ICD-10 Finland
Depressive episode
2.3
7.6
68
307
U02
ICPC
Urinary frequency/urgency
1.8
7.6
137
811
R01AD11
ATC
triamcinolone; nasal
2.0
7.6
95
495
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.1
7.6
82
402
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.9
7.6
114
635
M01AH02
ATC
rofecoxib; oral
1.9
7.6
103
556
K24
ICPC
Fear of heart disease
4.3
7.5
26
61
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
7.5
82
405
XG474
NOMESCO Finland
Exhalation nntrogen oxide
3.6
7.5
32
91
WX110
NOMESCO Finland
Local anesthesy
1.4
7.5
711
6160
N17
ICPC
Vertigo/dizziness
2.0
7.5
92
477
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
7.5
119
680
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
7.4
61
263
H92.0
ICD-10 Finland
Otalgia
2.5
7.4
56
233
R39.1
ICD-10 Finland
Other difficulties with micturition
4.6
7.4
24
53
J01EA01
ATC
trimethoprim; systemic
1.6
7.4
239
1663
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.7
7.4
30
82
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
2.3
7.4
66
297
L12
ICPC
Hand/finger symptom/complaint
1.8
7.4
140
844
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.1
7.4
78
379
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
7.3
194
1287
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.8
7.3
23
49
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.7
7.3
47
177
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.9
7.3
114
644
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.6
7.3
52
209
M01AH03
ATC
valdecoxib; oral
2.4
7.3
58
247
F99
ICD-10 Finland
Mental disorder, not otherwise specified
4.2
7.3
26
63
R52.0
ICD-10 Finland
Acute pain
4.2
7.3
26
63
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
5.0
7.3
22
45
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
+∞
7.3
7
*
79199
ICD-8 Finland
Headache
+∞
7.3
7
*
T90
ICPC
Diabetes non-insulin dependent
1.7
7.3
157
985
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
5.2
7.3
21
41
LCA06
NOMESCO Finland
Biopsy of endometrium
1.8
7.2
122
707
ZXA00
NOMESCO Finland
Right side
1.6
7.2
204
1373
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.2
7.2
36
116
R5140
NOMESCO Finland
Monitoring the use of the aid
2.1
7.2
77
376
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.8
7.2
132
788
R52.1
ICD-10 Finland
Chronic intractable pain
30.2
7.2
9
*
G04CA01
ATC
alfuzosin; oral
2.4
7.1
57
244
C10AA05
ATC
atorvastatin; oral
1.5
7.1
247
1750
K59.09
ICD-10 Finland
Constipation, unspecified
2.9
7.1
42
151
R07.0
ICD-10 Finland
Pain in throat
2.2
7.1
70
331
H25.8
ICD-10 Finland
Other senile cataract
2.2
7.1
69
322
F41.09
ICD-10 Finland
UNS Panic Syndrome
3.0
7.1
38
129
N06AX17
ATC
milnacipran; oral
6.1
7.1
18
30
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
7.1
743
6519
SPAT1053
SPAT
Memory test
2.0
7.1
87
451
K29.7
ICD-10 Finland
Gastritis, unspecified
3.2
7.1
34
107
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
7.0
59
259
D06
ICPC
Abdominal pain localized other
2.0
7.0
85
439
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
3.2
7.0
35
113
XKD03
NOMESCO Finland
Urethral pressure profilometry
4.0
7.0
26
66
T82
ICPC
Obesity
3.0
7.0
37
125
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
7.0
96
519
M54.3
ICD-10 Finland
Sciatica
2.5
7.0
53
222
C08DA01
ATC
verapamil; systemic
3.1
6.9
36
120
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
6.9
141
870
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.4
6.9
55
235
M02AA07
ATC
piroxicam; topical
1.5
6.9
292
2157
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
6.9
71
344
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
3.4
6.9
31
93
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.1
6.9
35
115
C03DA01
ATC
spironolactone; oral
2.2
6.9
68
323
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.3
6.9
63
289
E66.8
ICD-10 Finland
Other obesity
2.5
6.8
51
210
N03AX11
ATC
topiramate; oral
3.6
6.8
29
83
N06BA04
ATC
methylphenidate; oral
3.2
6.8
34
110
N05AF01
ATC
flupentixol; systemic
5.1
6.8
20
40
K60.1
ICD-10 Finland
Chronic anal fissure
4.0
6.8
25
63
M47.9
ICD-10 Finland
Spondylosis, unspecified
3.8
6.8
27
73
C10AX09
ATC
ezetimibe; oral
2.1
6.7
76
382
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
2.9
6.7
39
139
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
3.3
6.7
31
95
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
6.7
88
469
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.6
6.7
45
177
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
6.7
78
398
C09CA01
ATC
losartan; oral
1.6
6.7
162
1051
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.9
6.7
90
485
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
6.6
112
651
N76.0
ICD-10 Finland
Acute vaginitis
2.0
6.6
82
427
M01AB55
ATC
diclofenac, combinations; oral
2.3
6.6
56
246
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
2.0
6.6
80
413
D09
ICPC
Nausea
2.4
6.6
51
215
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.9
6.6
92
501
D06BX01
ATC
metronidazole; topical
1.8
6.6
105
599
R30.0
ICD-10 Finland
Dysuria
2.9
6.6
38
134
L50.3
ICD-10 Finland
Dermatographic urticaria
3.8
6.6
26
70
B02AA02
ATC
tranexamic acid; systemic
1.7
6.6
146
923
R03BA08
ATC
ciclesonide; inhalant
2.0
6.6
79
406
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.7
6.6
144
905
S10
ICPC
Boil/carbuncle
2.4
6.6
55
239
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.8
6.6
111
644
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
3.4
6.6
29
86
K10.3
ICD-10 Finland
Alveolitis of jaws
2.5
6.5
49
201
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
2.7
6.5
42
158
J01AA04
ATC
lymecycline; systemic
1.7
6.5
153
978
I73.0
ICD-10 Finland
Raynaud syndrome
4.2
6.5
23
56
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
4.0
6.5
24
61
D02AE01
ATC
carbamide; topical
2.1
6.5
68
332
XKC03
NOMESCO Finland
Water cystometry
3.5
6.4
28
82
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
6.4
86
460
H53.2
ICD-10 Finland
Diplopia
3.6
6.4
27
77
N05AF03
ATC
chlorprothixene; systemic
3.6
6.4
27
77
C10AA01
ATC
simvastatin; oral
1.5
6.4
266
1954
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.9
6.4
37
131
A29
ICPC
General symptom/complaint other
2.0
6.4
84
447
H02AB09
ATC
hydrocortisone; systemic
3.8
6.4
25
67
R03BA02
ATC
budesonide; inhalant
1.6
6.4
164
1079
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.8
6.4
113
665
L29
ICPC
Musculoskeletal sympt/complt other
2.1
6.4
67
327
ZXA10
NOMESCO Finland
Bilateral
1.6
6.4
153
987
R09
ICPC
Sinus symptom/complaint
1.9
6.4
90
494
RF120
NOMESCO Finland
NA
6.6
6.3
15
23
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
5.2
6.3
18
35
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
3.0
6.3
33
111
R32
ICD-10 Finland
Unspecified urinary incontinence
3.6
6.3
26
73
SBB10
NOMESCO Finland
Teeth copy
2.0
6.3
79
414
Z01.7
ICD-10 Finland
Laboratory examination
1.8
6.3
107
625
QAZ00
NOMESCO Finland
Botulin injections for hyperhidrosis of head and neck
+∞
6.3
6
*
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.5
6.2
27
79
D95
ICPC
Anal fissure/perianal abscess
7.1
6.2
14
20
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
3.3
6.2
29
90
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.9
6.2
94
527
S02
ICPC
Pruritus
2.6
6.2
41
159
G25.0
ICD-10 Finland
Essential tremor
4.0
6.2
23
59
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
2.2
6.2
61
290
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.4
6.2
345
2683
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
1.9
6.2
82
438
A99
ICPC
Disease/condition unspecnature/site
2.1
6.2
65
316
C10AC01
ATC
colestyramine; oral
3.1
6.1
31
102
L10
ICPC
Elbow symptom/complaint
2.5
6.1
45
186
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.3
6.1
21
50
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
4.3
6.1
21
50
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
4.3
6.1
21
50
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.7
6.1
118
717
H81
ICPC
Excessive ear wax
1.7
6.1
116
700
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
6.1
171
1147
SPAT1043
SPAT
Audiometry
2.0
6.1
78
413
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.1
6.1
69
346
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
6.1
219
1559
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
4.9
6.1
18
37
G04BD07
ATC
tolterodine; oral
2.7
6.1
39
147
M01AX05
ATC
glucosamine; oral
1.7
6.0
136
862
L05
ICPC
Flank/axilla symptom/complaint
2.4
6.0
47
200
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.7
6.0
128
797
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.9
6.0
35
125
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.7
6.0
39
148
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
4.2
6.0
21
51
I95.1
ICD-10 Finland
Orthostatic hypotension
4.0
6.0
22
56
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3036481) Cortisol [Moles/volume] in Serum or Plasma
281
700
4.90
107.08
2.1
1.8
nmol/l
346.0
386.6
2.30
258
637
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
105
91
12.51
103.63
1.2
1.1
nmol/l
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
101
96
11.37
93.73
1.2
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
762
4626
2.68
60.85
6.1
5.1
e9/l
0.2
0.2
0.12
683
4115
(3013707) Erythrocyte sedimentation rate by Westergren method
983
6871
3.08
58.23
5.2
3.3
mm/h
9.3
10.1
1.42
919
6352
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
651
3734
2.57
57.35
5.4
5.3
mmol/l
1.2
1.2
0.01
536
3173
(3006315) Basophils [#/volume] in Blood
732
4471
2.56
55.88
6.0
4.8
e9/l
0.0
0.0
0.89
650
3900
(3001604) Monocytes [#/volume] in Blood
726
4455
2.52
54.29
6.0
4.8
e9/l
0.5
0.6
1.11
644
3884
(3019198) Lymphocytes [#/volume] in Blood
745
4650
2.51
53.32
6.0
4.8
e9/l
2.0
2.0
0.00
676
4140
(3013650) Neutrophils [#/volume] in Blood by Automated count
790
5179
2.45
49.00
7.6
7.1
e9/l
3.9
4.0
0.24
701
4546
(42870588) Differential panel, method unspecified - Blood
513
2794
2.43
48.36
5.4
4.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
579
3345
2.37
47.51
4.8
4.6
mmol/l
1.2
1.2
0.18
521
3021
(3002030) Lymphocytes/100 leukocytes in Blood
702
4444
2.34
46.05
6.1
4.8
%
30.0
29.4
0.90
637
4145
(3022096) Basophils/100 leukocytes in Blood
654
4040
2.31
45.16
6.2
4.9
%
0.7
0.7
1.52
597
3750
(3019069) Monocytes/100 leukocytes in Blood
677
4249
2.31
44.93
6.3
5.0
%
8.2
8.2
0.05
619
3974
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1044
7971
2.97
44.43
5.6
3.8
pmol/l
14.5
14.5
0.53
980
7317
(3006504) Eosinophils/100 leukocytes in Blood
672
4222
2.29
44.26
6.1
4.8
%
2.9
2.8
0.67
615
3909
(3024561) Albumin [Mass/volume] in Serum or Plasma
558
3257
2.30
43.70
3.9
3.9
g/l
37.3
36.5
2.65
510
3029
(3018010) Neutrophils/100 leukocytes in Blood
688
4396
2.27
43.09
5.9
4.7
%
56.0
56.5
0.57
631
4111
(3015377) Calcium [Moles/volume] in Serum or Plasma
482
2693
2.29
41.36
2.6
2.8
mmol/l
2.3
2.4
1.90
410
2361
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
649
4128
2.20
40.09
5.1
4.6
umol/l
9.8
11.0
2.42
611
3875
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
179
625
3.18
39.81
2.5
3.3
pmol/l
4.6
4.6
0.02
151
557
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
924
6808
2.41
39.44
7.4
5.6
u/l
72.9
74.6
0.76
867
6346
(3013826) Glucose [Moles/volume] in Serum or Plasma
716
4759
2.20
39.26
4.3
3.6
mmol/l
6.4
6.5
0.45
661
4271
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
595
3738
2.14
36.98
2.6
2.1
nmol/l
75.1
75.5
0.11
537
3400
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
531
3201
2.15
36.66
2.1
1.8
pmol/l
97.3
97.3
0.00
258
1658
(3017446) Testosterone [Moles/volume] in Serum or Plasma
153
512
3.27
36.40
2.4
2.0
nmol/l
10.6
12.1
1.15
128
462
(3001122) Ferritin [Mass/volume] in Serum or Plasma
705
4749
2.12
36.18
3.1
2.6
ug/l
97.4
85.8
0.79
648
4434
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
177
650
3.01
35.92
2.8
3.2
u/l
216.5
243.5
1.65
161
618
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
436
2470
2.18
34.93
2.6
2.0
u/l
54.8
56.9
0.68
399
2276
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
380
2059
2.22
33.85
2.3
2.0
mg/l
2.7
2.9
0.63
317
1762
(3037522) Nuclear Ab [Titer] in Serum
260
1196
2.49
33.85
1.5
1.3
titre
697.9
527.3
0.47
56
241
(3037467) Urinalysis macro (dipstick) panel - Urine
880
6596
2.15
32.28
5.2
3.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
368
2008
2.18
31.92
2.3
1.8
u/l
137.0
231.2
1.68
337
1878
(3021960) Folate [Moles/volume] in Serum or Plasma
328
1723
2.23
31.17
1.6
1.4
nmol/l
21.9
21.5
0.16
267
1472
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1115
9337
2.94
30.28
6.8
4.5
mu/l
1.7
1.8
3.29
1053
8680
(3019309) Folate [Moles/volume] in Red Blood Cells
258
1247
2.35
29.74
1.8
1.6
nmol/l
1160.8
1170.8
0.06
187
948
(3018418) pH of Serum or Plasma
380
2156
2.10
29.40
3.9
3.2
ph
7.4
7.4
0.19
80
387
(3031040) Bacteria [#/volume] in Urine by Automated count
835
6256
2.03
29.00
5.2
3.5
e6/l
41.9
3195.1
—
7
75
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
312
1651
2.19
28.83
1.4
1.2
iu/ml
23.0
32.0
0.84
82
536
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1038
8510
2.35
27.55
6.1
4.7
mmol/mol
38.5
38.5
0.06
963
7977
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
335
1863
2.09
26.99
1.8
1.5
mg/l
0.8
1.0
1.97
245
1374
(3048689) Calprotectin [Mass/mass] in Stool
252
1254
2.27
26.89
2.1
2.3
ug/g
79.5
98.5
1.05
181
988
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
313
1701
2.12
26.77
3.4
2.5
ng/l
991.0
1021.3
0.07
258
1385
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
294
1575
2.14
26.02
1.4
1.2
u/ml
8.2
12.8
0.57
103
640
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
84
239
3.70
25.55
1.2
1.3
u/ml
8.0
54.1
—
5
19
(3035637) Corticotropin [Mass/volume] in Plasma
46
81
5.86
25.20
1.7
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
105
353
3.16
24.58
1.4
1.3
u/l
11.0
9.7
0.44
83
295
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
50
98
5.27
24.44
1.6
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
119
436
2.91
23.96
2.1
2.7
g/l
67.3
67.5
0.11
108
398
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
255
1332
2.15
23.88
2.3
2.4
mmol/l
2.4
2.4
3.47
220
1164
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
78
221
3.70
23.86
1.2
1.3
u/ml
12.6
8.7
0.14
11
42
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
398
2442
1.93
23.80
1.4
1.2
u/ml
1.0
1.4
0.50
103
655
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
71
189
3.92
23.74
1.6
1.3
u/l
29.1
21.8
0.92
58
159
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
77
218
3.70
23.58
1.2
1.3
u/ml
1.4
2.4
—
7
27
(40760892) CBC W Ordered Manual Differential panel - Blood
359
2159
1.93
22.60
4.3
3.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
422
2680
1.87
22.44
4.2
2.6
ng/l
28.6
58.3
0.87
253
1487
(3007164) IgA [Mass/volume] in Serum or Plasma
335
1974
1.96
22.36
1.6
1.3
g/l
2.1
2.2
0.19
218
1187
(3033923) Metanephrine [Moles/time] in 24 hour Urine
23
20
11.70
22.28
1.1
1.0
umol/24h
0.7
0.7
—
5
11
(3005322) IgE [Units/volume] in Serum or Plasma
146
620
2.54
22.01
1.3
1.3
u/ml
122.5
243.2
1.89
137
577
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1138
9970
2.73
21.94
15.1
8.9
mg/l
18.4
21.2
2.58
923
7437
(40768797) Stomach Pathology biopsy report
220
1119
2.17
21.90
1.2
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
148
635
2.51
21.83
1.6
1.4
iu/l
21.4
24.6
0.64
134
545
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
852
6738
1.85
21.47
3.6
2.5
u/l
42.3
36.4
1.40
811
6381
(3004588) Protein electrophoresis panel - Serum or Plasma
99
349
3.00
21.33
2.0
2.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
644
4696
1.77
21.30
4.3
2.9
estimate
0.0
0.0
0.50
131
875
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
30
40
7.66
21.28
2.2
1.9
nmol/l
0.9
1.9
0.87
21
29
(3022948) Iron [Moles/volume] in Serum or Plasma
216
1111
2.14
20.82
1.9
2.0
umol/l
15.7
14.1
2.04
196
1022
(3023368) Bacteria identified in Blood by Culture
291
1673
1.97
20.67
4.1
3.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
284
1631
1.96
20.18
1.8
1.6
pmol/l
45378592.0
28385652.8
0.14
238
1381
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
189
941
2.19
19.72
7.5
5.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
644
4767
1.73
19.57
4.4
3.0
estimate
0.0
0.0
1.06
128
867
(3026008) Bacteria identified in Urine by Culture
399
2582
1.80
19.41
3.5
2.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
638
4719
1.73
19.37
5.9
4.1
estimate
0.0
0.0
0.50
136
890
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
121
499
2.58
19.33
1.2
1.3
au/ml
29.4
39.3
—
6
26
(3005719) IgG [Mass/volume] in Serum or Plasma
127
537
2.52
19.26
2.5
2.6
g/l
9.7
10.8
2.98
113
482
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
129
552
2.49
19.07
2.3
2.4
au/ml
48.7
21.6
—
7
45
(3015736) pH of Urine
515
3614
1.73
18.73
3.9
2.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
89
318
2.94
18.71
1.9
1.9
u/l
39.8
40.9
0.23
80
292
(46235355) HIV 1 and 2 tests - Meaningful Use set
421
2797
1.77
18.56
2.1
2.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
181
907
2.17
18.53
1.9
2.1
%
25.5
23.6
0.94
155
762
(3012095) Magnesium [Moles/volume] in Serum or Plasma
199
1036
2.10
18.45
3.2
2.7
mmol/l
0.8
0.8
0.26
181
980
(3023103) Potassium [Moles/volume] in Serum or Plasma
1115
9862
2.30
17.77
16.4
9.9
mmol/l
3.9
3.9
0.62
1085
9524
(3019550) Sodium [Moles/volume] in Serum or Plasma
1112
9826
2.28
17.74
16.4
9.8
mmol/l
139.7
139.7
0.29
1083
9510
(3015171) Extractable nuclear Ab [Units/volume] in Serum
89
328
2.85
17.68
1.3
1.3
u/ml
0.3
1.3
—
10
27
(3003458) Phosphate [Moles/volume] in Serum or Plasma
169
845
2.16
17.35
3.8
4.7
mmol/l
1.0
1.0
0.04
155
787
(3013512) EKG study
334
2108
1.80
17.34
4.6
3.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
61
182
3.47
17.28
1.3
1.3
ug/g
343.6
310.7
0.52
32
98
(3004789) Transferrin [Mass/volume] in Serum or Plasma
188
996
2.05
16.53
1.9
2.0
g/l
2.5
2.4
0.98
165
915
(3030467) Casts [#/volume] in Urine by Automated count
329
2093
1.78
16.51
3.3
2.5
e6/l
0.4
0.4
0.16
260
1510
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
77
273
2.94
16.41
1.4
2.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
413
2810
1.70
16.27
7.5
6.2
inr
1.2
1.2
0.08
114
857
(3021387) Prolactin [Units/volume] in Serum or Plasma
125
567
2.34
16.20
1.6
1.6
mu/l
282.1
306.0
0.64
113
511
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1066
9344
2.01
16.19
4.9
3.7
mmol/l
5.8
5.7
1.25
983
8617
(3009508) Creatinine [Moles/volume] in Urine
382
2550
1.72
16.11
3.9
3.2
mmol/l
8.1
7.7
0.79
312
2172
(3019225) pH of Specimen
150
742
2.16
15.77
3.5
3.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
164
843
2.09
15.60
1.2
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
374
2501
1.71
15.58
1.7
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
81
304
2.78
15.56
1.5
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
309
1960
1.77
15.54
2.6
2.1
umol/l
1341.6
5617.4
2.50
273
1725
(3002582) Erythrocytes [#/volume] in Urine
350
2304
1.72
15.42
3.4
2.6
e6/l
262.3
96.1
0.31
275
1700
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
506
3669
1.64
15.41
4.5
3.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
114
508
2.37
15.37
2.7
3.7
ng/l
64.8
79.0
1.84
88
450
(3023520) Reticulocytes [#/volume] in Blood
106
461
2.42
15.09
2.3
2.3
e9/l
69.8
69.6
0.02
85
332
(36304419) Bacteria [Presence] in Urine
322
2083
1.74
15.05
3.2
2.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
257
1557
1.82
15.03
2.7
2.2
e6/l
7.6
7.2
0.08
223
1355
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
105
457
2.42
14.92
1.6
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
116
528
2.32
14.90
1.4
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
97
408
2.49
14.84
2.3
1.6
g/l
1.4
1.3
0.18
89
372
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
424
2968
1.65
14.68
3.3
2.7
u/l
31.4
29.9
0.29
402
2830
(3022145) Colonoscopy Study observation
172
925
2.00
14.42
1.3
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1168
10704
2.59
14.36
11.5
7.7
u/l
26.3
25.3
0.99
1123
10306
(40768443) Skin Pathology biopsy report
83
329
2.63
14.34
1.3
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
142
720
2.10
13.96
17.3
21.9
inr
1.2
1.3
0.47
22
93
(3018095) Leukocytes [#/volume] in Urine
417
2949
1.62
13.65
4.0
3.0
e6/l
88.3
65.0
0.29
299
1879
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
161
863
1.99
13.59
1.4
1.2
iu/ml
98.5
158.8
1.34
53
336
(3026782) Osmolality of Urine
237
1443
1.79
13.50
3.5
2.3
mosm/kgh2o
528.0
553.9
0.91
206
1224
(3012516) Albumin [Mass/volume] in Urine
328
2188
1.68
13.48
3.5
3.3
mg/l
1089.8
207.4
1.23
196
1369
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
179
1000
1.92
13.39
1.9
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
53
171
3.19
13.30
1.5
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
100
449
2.33
13.25
2.4
1.9
ug/l
3.8
6.6
1.66
85
396
(3007853) Bacteria identified in Skin by Aerobe culture
170
937
1.94
13.23
1.7
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
56
188
3.07
13.15
2.1
2.0
mg/l
9.9
10.5
0.24
49
175
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
126
627
2.12
13.00
2.6
2.0
g/l
0.2
0.2
0.39
117
588
(3011397) Hemoglobin [Presence] in Urine by Test strip
312
2076
1.67
12.87
4.0
2.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
360
2493
1.63
12.65
4.6
3.1
estimate
0.0
0.0
0.34
133
881
(3017143) Hepatitis C virus Ab [Presence] in Serum
225
1376
1.78
12.56
1.7
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
68
261
2.70
12.53
2.0
3.4
g/l
0.2
0.3
1.35
25
102
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
204
1213
1.82
12.51
1.7
1.6
%
1.4
1.4
1.17
175
1105
(40761535) Cells panel - Urine sediment
123
616
2.11
12.47
3.9
2.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
186
1076
1.86
12.46
1.9
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
207
1239
1.81
12.41
3.7
2.8
ng/l
197.1
587.4
1.76
135
847
(3020682) Albumin/Creatinine [Ratio] in Urine
337
2306
1.63
12.39
4.1
4.0
mg/mmol
7.4
8.7
0.30
199
1443
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
14
14
10.10
12.25
1.7
1.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
303
2028
1.65
12.12
4.3
3.2
kg/l
1.0
1.0
0.17
45
313
(3027945) Reticulocytes/100 erythrocytes in Blood
131
680
2.04
12.06
2.2
2.3
%
1.7
1.7
0.30
107
603
(3009445) Proteinase 3 Ab [Units/volume] in Serum
66
256
2.67
11.93
1.2
1.6
—
15.0
—
0
7
(3044290) Cell count panel - Cerebral spinal fluid
39
111
3.60
11.91
1.1
1.8
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
137
731
1.98
11.68
3.7
6.2
mmol/l
104.5
104.6
0.09
132
715
(40768804) Tissue Pathology biopsy report
505
3841
1.53
11.58
2.1
1.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
154
879
1.86
10.71
2.6
2.2
umol/l
5.3
7.2
1.70
132
744
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
94
450
2.18
10.69
2.5
2.7
ng/l
94.8
148.9
2.01
84
401
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
70
295
2.46
10.69
1.0
1.1
u/ml
1.6
5.8
—
5
37
(3009343) pH of Capillary blood
84
386
2.26
10.56
2.5
3.5
ph
7.4
7.4
—
8
35
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
19
33
5.83
10.55
1.5
1.5
pmol/l
13.3
14.2
—
10
25
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
51
186
2.82
10.39
2.6
2.6
g/l
2.7
3.1
2.29
41
147
(3002032) Base excess in Venous blood by calculation
105
531
2.07
10.37
3.7
3.2
mmol/l
2.1
1.6
0.62
89
416
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1024
9184
1.66
10.28
13.2
8.2
ml/min/173m2
88.5
87.8
0.43
845
7225
(3028192) IgG subclass 2 [Mass/volume] in Serum
24
53
4.60
10.27
1.4
1.2
g/l
2.6
3.1
0.74
15
36
(3024139) IgG subclass 3 [Mass/volume] in Serum
24
53
4.60
10.27
1.4
1.2
g/l
0.5
0.4
0.16
15
37
(3027135) IgG subclass 1 [Mass/volume] in Serum
24
53
4.60
10.27
1.4
1.2
g/l
6.1
7.3
0.69
15
37
(3044889) 12 lead EKG panel
732
6110
1.48
10.17
3.9
3.0
—
—
—
0
0
(4062490)
24
54
4.51
10.04
1.5
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
164
975
1.79
9.97
1.4
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
202
2.70
9.94
2.6
2.5
g/l
7.0
7.4
0.92
41
152
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
202
2.70
9.94
2.6
2.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
81
377
2.23
9.88
2.4
3.5
mmol/l
0.8
1.5
0.71
60
279
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
304
2130
1.57
9.80
2.7
2.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
31
87
3.63
9.69
1.3
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
277
1905
1.58
9.66
2.6
2.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
122
668
1.92
9.62
1.8
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
189
2.71
9.54
2.7
2.5
g/l
10.3
10.6
0.23
42
163
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
202
2.64
9.41
2.6
2.5
g/l
3.7
3.9
0.92
38
142
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
57
232
2.53
9.39
1.6
1.5
nmol/l
0.3
0.5
1.32
43
198
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
122
674
1.90
9.37
1.8
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
38
125
3.10
9.30
1.1
1.4
mmol/l
3.6
3.6
0.01
33
119
(3041096) Erythrocytes [Presence] in Urine by Automated
368
2723
1.50
9.12
3.9
2.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
36
116
3.17
9.12
1.2
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
40
138
2.96
9.03
2.6
4.6
mg/l
21.0
35.5
1.00
30
114
(3034860) Kappa light chains.free [Mass/volume] in Serum
40
138
2.96
9.03
2.6
4.5
mg/l
68.6
84.6
0.10
30
112
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
193
1234
1.67
9.00
3.0
2.2
e6/l
1.0
1.1
0.21
121
661
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
37
123
3.07
8.90
1.2
1.8
e6/l
106.2
2459.9
0.88
29
98
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
37
123
3.07
8.90
1.1
1.7
e6/l
20.8
12.5
0.18
27
94
(3024980) IgG subclass 4 [Mass/volume] in Serum
32
98
3.33
8.79
1.5
1.3
g/l
0.6
0.8
0.34
22
75
(40761511) CBC panel - Blood by Automated count
1154
10807
1.99
8.74
14.6
8.9
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
63
279
2.33
8.66
1.7
1.6
iu/ml
0.1
0.3
—
10
53
(3044640) Blood type and Crossmatch panel - Blood
372
2785
1.48
8.62
2.2
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
292
2080
1.53
8.60
2.2
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
527
4219
1.43
8.56
10.6
7.0
e9/l
0.0
0.0
0.82
440
3459
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
29
85
3.47
8.53
1.2
1.4
pmol/l
322.5
324.9
0.01
20
64
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
108
592
1.90
8.49
3.8
2.6
mmol/l
1.2
1.2
0.06
99
500
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
553
4470
1.43
8.49
4.1
3.7
—
—
—
0
0
(3010421) pH of Blood
39
138
2.89
8.43
3.2
2.7
ph
7.4
7.4
0.07
33
112
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
76
371
2.12
8.26
2.2
2.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
303
2193
1.51
8.24
6.2
5.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1071
9847
1.65
8.23
5.0
4.1
mmol/l
2.8
2.8
1.28
984
9194
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
39
140
2.84
8.22
2.8
2.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1059
9711
1.62
8.21
4.6
3.7
mmol/l
4.7
4.8
1.75
981
9124
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
41
152
2.76
8.15
1.2
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1054
9659
1.61
8.13
4.6
3.7
mmol/l
1.5
1.5
1.90
975
9026
(3012501) Base excess in Blood by calculation
34
114
3.04
8.08
3.6
2.9
mmol/l
3.2
2.6
0.38
21
69
(3021440) Promyelocytes/100 leukocytes in Blood
114
648
1.84
8.01
5.3
3.3
%
0.2
0.1
0.64
25
123
(3000991) Gas panel - Venous blood
91
482
1.96
7.93
4.4
7.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1018
9271
1.55
7.90
4.2
3.3
mmol/l
1.3
1.2
2.66
937
8621
(3013139) Helicobacter pylori Ag [Presence] in Stool
110
622
1.84
7.86
1.3
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
60
272
2.27
7.84
1.5
1.3
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
21
52
4.09
7.82
2.4
3.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
33
111
3.03
7.81
3.0
2.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
22
57
3.91
7.72
1.1
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
116
673
1.80
7.63
5.3
3.2
%
0.8
0.8
0.03
27
138
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
121
711
1.78
7.63
2.1
1.9
u/l
74.2
37.1
0.44
105
587
(40760888) Immunoglobulin light chains.free panel - Serum
31
102
3.09
7.62
2.4
4.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
109
622
1.82
7.57
5.2
3.1
%
0.4
0.4
0.04
17
102
(3022313) Gas panel - Capillary blood
64
303
2.17
7.54
2.3
3.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
34
120
2.89
7.41
1.1
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
111
644
1.79
7.31
2.6
2.4
e9/l
3.8
4.1
0.85
78
539
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
45
187
2.46
7.16
1.9
1.8
ug/l
0.6
1.7
1.13
36
166
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
11
16
6.93
7.16
1.1
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
40
159
2.57
6.98
3.1
2.5
g/l
40.3
38.4
1.90
35
138
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
23
67
3.48
6.86
1.0
1.1
—
—
—
0
0
(3020891) Body temperature
50
224
2.28
6.75
3.8
4.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
267
1955
1.47
6.71
3.9
3.0
%
96.9
94.9
0.70
259
1898
(3025159) Blasts/100 leukocytes in Blood
106
624
1.76
6.65
5.5
3.3
%
0.0
0.9
0.56
18
109
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
172
1152
1.57
6.57
3.3
2.4
e6/l
4.1
3.2
0.40
99
588
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
23
69
3.38
6.57
1.2
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
20
55
3.68
6.49
1.1
2.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
869
7783
1.39
6.40
3.8
3.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
19
51
3.77
6.37
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
19
51
3.77
6.37
1.2
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
73
388
1.94
6.34
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
114
2.76
6.31
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
114
2.76
6.31
1.5
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
104
619
1.74
6.29
1.1
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
32
120
2.71
6.28
1.2
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
189
1307
1.53
6.25
2.2
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
154
1021
1.58
6.14
2.1
1.8
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
52
247
2.15
6.12
1.8
1.8
g/l
1.2
1.4
0.83
43
213
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
159
1063
1.57
6.12
4.4
3.9
%
32.4
32.3
0.04
106
742
(3037756) Immunofixation for Serum or Plasma
27
94
2.91
6.07
1.1
1.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
19
54
3.56
5.89
1.2
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
77
428
1.85
5.85
1.9
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
55
272
2.07
5.85
1.8
2.0
iu/l
3.2
5.4
1.64
25
114
(3007461) Platelets [#/volume] in Blood
1202
11592
2.24
5.74
23.1
13.9
e9/l
260.9
259.3
0.39
1174
11284
(44790049)
21
65
3.27
5.74
1.0
1.3
—
—
—
0
0
(44790047)
21
65
3.27
5.74
1.0
1.3
—
—
—
0
0
(44790048)
21
65
3.27
5.74
1.0
1.3
—
—
—
0
0
(44806118)
21
65
3.27
5.74
1.0
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
36
151
2.43
5.67
1.0
1.1
u/ml
0.9
2.5
1.66
18
73
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
101
616
1.70
5.61
2.2
2.6
ml/min/173m2
74.5
74.0
0.03
39
217
(3008898) HLA-B27 [Presence]
71
390
1.87
5.61
1.1
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
107
663
1.67
5.61
3.9
7.0
mmol/l
0.7
0.8
0.11
83
524
(3000963) Hemoglobin [Mass/volume] in Blood
1203
11615
2.23
5.56
23.2
13.9
g/l
136.0
135.4
0.85
1186
11448
(3024731) MCV [Entitic volume]
1202
11603
2.20
5.54
23.0
13.8
fl
90.5
90.2
2.15
1184
11437
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
22
72
3.09
5.51
1.0
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
1202
11605
2.20
5.50
23.0
13.8
pg
30.2
30.1
3.38
1185
11438
(3026361) Erythrocytes [#/volume] in Blood
1202
11607
2.19
5.46
23.0
13.8
e12/l
4.5
4.5
0.25
1172
11282
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
51
252
2.07
5.46
1.3
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1202
11609
2.19
5.43
23.1
13.9
e9/l
6.8
6.7
1.25
1172
11277
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
5
16.10
5.41
1.6
1.0
ng/l
67.8
93.8
—
8
5
(3011288) Drugs identified in Urine by Screen method
73
411
1.82
5.35
7.2
2.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
10
18
5.59
5.33
1.9
1.9
umol/l
17.9
13.3
—
10
18
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
19
58
3.31
5.32
1.2
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
12
26
4.65
5.26
1.0
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
301
2343
1.38
5.23
1.7
1.7
—
—
—
0
0
(3000492) Spirometry study
139
934
1.55
5.23
1.4
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
19
59
3.25
5.18
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
28
109
2.61
5.16
1.4
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
186
1333
1.47
5.15
1.8
1.9
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
64
352
1.86
5.06
5.0
7.1
mmol/l
24.7
24.5
0.21
59
327
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
45
3.59
5.05
1.1
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22
76
2.93
5.05
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
32
136
2.39
4.93
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
28
112
2.53
4.90
2.4
2.6
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
44
215
2.09
4.88
1.3
1.2
—
561.3
—
0
8
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
20
67
3.02
4.84
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
20
67
3.02
4.84
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
20
67
3.02
4.84
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
28
4.32
4.83
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
60
329
1.87
4.80
1.2
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
23
84
2.77
4.79
1.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
24
4.62
4.78
1.1
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
20
5.03
4.78
2.1
2.8
u/ml
394.7
531.3
—
10
20
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
20
68
2.97
4.72
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
20
68
2.97
4.72
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
20
68
2.97
4.72
1.2
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
26
104
2.53
4.56
3.0
2.1
%
17.8
17.3
—
10
53
(4010399)
94
596
1.62
4.54
1.4
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
21
4.79
4.53
2.0
1.6
ug/l
8.5
8.4
—
10
21
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
20
70
2.89
4.50
1.3
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
32
142
2.29
4.50
2.5
3.8
e9/l
3.7
3.8
0.11
32
142
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
44
3.44
4.47
1.3
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
36
169
2.16
4.44
1.2
1.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
89
560
1.63
4.44
4.1
7.6
g/l
124.6
121.2
0.82
84
538
(3021879) Hepatitis B virus core Ab [Presence] in Serum
129
885
1.51
4.43
1.6
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
41
203
2.05
4.41
2.1
2.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
31
137
2.30
4.41
1.3
1.2
u/ml
8.4
5.9
0.17
13
55
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
46
238
1.97
4.39
2.0
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
46
239
1.96
4.35
7.6
2.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
246
1908
1.36
4.31
1.8
1.7
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
18
61
2.98
4.29
2.2
1.4
%
89.5
91.3
0.66
18
61
(3009542) Hematocrit [Volume Fraction] of Blood
1042
9815
1.39
4.26
14.9
10.3
%
40.2
40.0
0.36
763
7721
(3002385) Erythrocyte distribution width [Ratio]
943
8751
1.32
4.25
17.1
11.4
%
13.4
13.5
0.76
927
8538
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
107
714
1.55
4.18
2.6
2.1
u/l
7041.3
6234.4
0.08
36
304
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
32
147
2.21
4.17
2.8
3.7
%
54.9
56.2
0.27
32
147
(3014765) Yersinia sp identified in Stool by Organism specific culture
49
265
1.88
4.13
1.3
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
33
155
2.16
4.08
1.3
1.2
u/ml
220.9
236.5
0.13
18
101
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
30
136
2.24
4.04
1.4
1.3
u/ml
8.5
4.2
—
10
50
(3020191) Ethanol [Moles/volume] in Serum or Plasma
16
53
3.05
3.97
1.3
1.3
promille
1.3
1.3
0.01
11
40
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
50
277
1.84
3.93
2.0
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
49
3.09
3.81
1.1
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
22
89
2.50
3.81
1.3
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
75
472
1.63
3.77
5.3
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
70
434
1.65
3.73
1.5
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
22
90
2.47
3.73
1.3
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
22
90
2.47
3.73
1.3
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
22
90
2.47
3.73
1.3
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
39
203
1.95
3.71
3.5
2.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
48
269
1.82
3.65
1.3
1.1
—
—
—
0
0
(4027681)
14
45
3.14
3.65
1.4
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
22
91
2.44
3.65
1.3
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
61
367
1.70
3.65
2.7
4.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
65
398
1.67
3.64
1.8
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
116
812
1.47
3.64
4.5
2.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
40
3.27
3.63
1.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
40
3.27
3.63
1.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
40
3.27
3.63
1.0
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
12
35
3.45
3.62
2.0
1.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
24
104
2.33
3.61
1.2
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
47
264
1.81
3.56
1.3
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
14
46
3.07
3.53
1.1
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
6
10.04
3.50
1.3
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
6
10.04
3.50
1.3
1.0
%
106.0
90.5
—
6
6
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
157
1174
1.39
3.44
4.5
3.8
%
21.9
22.0
0.02
61
501
(3036489) Thrombin time
51
297
1.75
3.44
2.1
1.7
s
21.2
21.0
0.10
45
254
(4268621)
22
94
2.36
3.42
2.5
2.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
30
147
2.07
3.38
1.3
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
28
134
2.11
3.35
1.3
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
89
2.38
3.33
1.3
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
29
143
2.05
3.23
2.4
2.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
58
358
1.65
3.19
1.9
1.4
—
—
—
0
0
(1002224) Polysomnography panel
67
430
1.59
3.15
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
74
487
1.55
3.13
1.7
1.5
mg/l
3.5
2.9
0.50
58
316
(3006922) Hepatitis E virus Ab [Presence] in Serum
14
50
2.82
3.09
1.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
19
80
2.40
3.07
1.1
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
11
34
3.26
3.06
1.3
1.4
—
51.4
—
0
7
(3042517) Benzodiazepines panel - Urine
6
8
7.53
3.05
2.0
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
37
204
1.84
3.01
2.8
5.7
mmol/l
1.3
1.2
0.22
32
178
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
35
190
1.87
2.99
1.2
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
186
1460
1.32
2.98
5.3
4.3
ug/l
2.0
2.3
0.30
162
1319
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
73
485
1.54
2.97
1.3
1.3
miu/ml
230.3
252.3
0.20
38
257
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
12
40
3.02
2.97
1.3
1.7
ug/l
19.9
230.1
0.48
12
33
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
283
2352
1.26
2.92
1.6
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
20
89
2.27
2.87
2.5
2.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
20
89
2.27
2.87
4.2
2.2
%
0.9
0.9
0.01
11
70
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
7
13
5.41
2.87
1.1
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
7
13
5.41
2.87
1.1
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
7
13
5.41
2.87
1.1
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
30
158
1.92
2.82
1.2
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
27
137
1.99
2.81
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
88
616
1.46
2.81
2.8
2.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
23
110
2.11
2.79
1.2
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
17
72
2.38
2.73
1.1
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
75
513
1.49
2.69
2.0
1.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
24
3.77
2.67
1.1
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
24
3.77
2.67
1.1
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
83
583
1.45
2.62
2.3
2.5
u/ml
16.2
43.3
3.02
78
566
(3021788) Differential panel - Synovial fluid
25
127
1.99
2.61
1.8
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
87
2.20
2.58
1.1
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
25
3.62
2.57
1.0
1.0
—
—
—
0
0
(4306422)
25
128
1.97
2.56
1.1
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
7
7.17
2.55
1.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
11
5.48
2.54
1.3
2.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
11
5.48
2.54
1.3
2.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
31
172
1.82
2.52
1.3
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
30
165
1.84
2.50
2.2
2.4
nmol/l
1.0
0.9
0.53
24
136
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
20
95
2.12
2.49
1.1
1.1
g/l
1.4
1.4
0.30
15
83
(3002256) Pathology report gross observation
145
1128
1.32
2.49
1.3
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
82
581
1.44
2.48
5.0
1.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
21
102
2.08
2.48
3.0
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
24
124
1.95
2.41
1.6
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
31
175
1.79
2.39
1.7
1.8
e6/l
8849.4
13484.3
0.40
21
128
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
27
3.35
2.39
1.3
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
9
27
3.35
2.39
1.7
1.6
nmol/l
132.9
143.9
—
9
27
(3000330) Specific gravity of Urine by Test strip
63
427
1.50
2.39
5.7
2.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
15
64
2.36
2.39
1.1
1.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
5
8
6.27
2.37
1.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
13
52
2.52
2.36
1.2
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
46
2.62
2.36
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
46
2.62
2.36
1.0
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
17
4.14
2.36
1.0
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
51
332
1.56
2.33
4.4
8.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
23
3.49
2.27
1.1
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
90
661
1.39
2.25
2.7
4.0
ug/l
4.4
7.8
0.92
67
515
(4146454)
17
79
2.17
2.25
2.1
2.8
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
9
29
3.12
2.22
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
54
361
1.52
2.21
1.7
1.7
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
24
3.35
2.18
1.4
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
61
2.31
2.15
1.1
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
68
2.22
2.11
3.9
2.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
8
25
3.21
2.09
1.1
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
86
636
1.38
2.08
4.8
1.9
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
9
31
2.92
2.07
1.1
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
17
82
2.09
2.07
3.5
2.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
20
3.51
2.05
1.0
3.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
85
631
1.37
2.02
4.8
1.9
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
278
2395
1.21
2.02
1.6
1.6
mmol/l
1.5
1.3
1.86
237
2065
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
38
2.64
2.01
1.3
3.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
32
2.83
2.00
1.3
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
25
141
1.79
1.98
1.4
1.3
u/ml
113.6
109.6
—
7
26
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
21
3.35
1.96
1.0
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
21
3.35
1.96
1.0
1.1
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
5
11
4.56
1.94
1.0
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
27
2.98
1.93
1.3
1.3
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
11
45
2.46
1.93
1.1
1.6
mu/l
278.5
449.6
1.31
11
45
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
10
39
2.58
1.92
1.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
84
629
1.36
1.91
2.5
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
85
639
1.35
1.88
4.9
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
24
136
1.78
1.88
1.1
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
19
100
1.91
1.86
1.3
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
59
2.22
1.84
2.8
2.5
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
12
4.18
1.82
1.0
1.1
umol/24h
1.3
1.8
—
5
12
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
53
2.28
1.81
2.4
2.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
98
758
1.32
1.81
3.6
2.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
29
2.77
1.79
1.3
1.3
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
11
47
2.35
1.78
1.1
1.6
%
73.2
73.1
0.01
11
47
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
42
281
1.51
1.76
1.2
1.3
ug/l
3.2
3.7
0.29
37
263
(3001019) Free T4 and TSH panel - Serum or Plasma
95
735
1.32
1.75
1.8
1.6
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
18
3.34
1.75
1.3
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
24
140
1.73
1.72
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
82
1.96
1.70
1.2
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
12
55
2.19
1.67
1.3
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
19
3.17
1.66
5.8
3.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
25
2.81
1.65
1.4
3.9
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
13
63
2.07
1.60
1.2
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
7
26
2.70
1.58
1.1
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
8
33
2.43
1.54
1.4
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
21
2.87
1.50
1.0
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
14
72
1.96
1.49
1.4
1.2
u/ml
0.7
1.1
—
7
29
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
30
195
1.55
1.46
1.6
1.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
10
45
2.23
1.46
1.6
1.5
u/l
3.4
4.6
—
5
20
(3004716) Salmonella sp identified in Stool by Organism specific culture
83
650
1.30
1.44
1.3
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
14
73
1.93
1.44
4.8
1.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
14
73
1.93
1.44
1.1
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
12
59
2.04
1.43
2.0
3.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
22
2.74
1.43
1.5
4.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
20
118
1.71
1.41
1.3
1.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
13
67
1.95
1.38
4.3
1.7
pg
32.8
32.5
0.17
13
67
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
18
104
1.74
1.37
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
105
856
1.25
1.34
3.2
2.8
ug/l
0.6
0.8
1.94
66
519
(4198724)
10
47
2.14
1.34
1.2
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
61
1.98
1.33
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
33
225
1.48
1.32
2.7
3.1
u/ml
493.6
1324.8
0.44
26
197
(40768441) Liver Pathology biopsy report
11
55
2.01
1.27
1.2
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
25
162
1.55
1.26
1.0
1.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
14
77
1.83
1.25
2.2
1.7
%
64.2
62.0
—
9
50
(3003694) ABO and Rh group [Type] in Blood
293
3244
0.87
1.25
1.7
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
25
2.41
1.24
6.3
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
25
2.41
1.24
1.0
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
25
2.41
1.24
1.0
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
25
2.41
1.24
1.0
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
25
2.41
1.24
1.0
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
36
2.23
1.24
1.0
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
12
63
1.91
1.23
1.3
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
10
49
2.05
1.22
2.2
2.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
27
180
1.51
1.21
1.3
1.3
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
14
78
1.80
1.21
1.0
1.1
u/ml
0.3
3.1
—
5
26
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
32
222
1.45
1.19
1.8
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
172
1492
1.18
1.18
1.5
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
11
57
1.94
1.17
1.2
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
20
2.51
1.15
1.0
1.0
—
—
—
0
0
(4094501)
28
191
1.48
1.14
1.1
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
16
95
1.69
1.14
1.9
2.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
31
217
1.44
1.12
2.5
1.9
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
21
2.39
1.09
1.2
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
32
2.19
1.08
1.3
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
35
253
1.39
1.07
1.2
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
19
290
0.65
1.07
1.2
1.2
—
—
—
0
0
(4035726)
80
652
1.24
1.06
1.3
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
19
121
1.58
1.06
2.0
3.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
33
237
1.40
1.05
1.2
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
12
67
1.80
1.05
2.2
2.8
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
32
229
1.41
1.04
1.1
1.1
u/ml
0.3
1.5
1.36
11
96
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
46
1.96
1.03
1.0
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
22
2.28
1.03
1.2
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
106
1.61
1.03
1.0
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
32
230
1.40
1.02
3.1
2.3
umol/l
4.2
4.9
0.41
25
167
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
23
155
1.49
1.01
2.5
2.7
u/ml
0.4
0.4
0.19
15
73
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
12
68
1.77
1.00
1.2
1.2
u/l
56.1
54.4
—
7
51
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
35
259
1.36
0.96
1.2
1.1
u/ml
1.5
1.9
0.12
13
97
(3003888) Timothy IgE Ab [Units/volume] in Serum
33
242
1.37
0.95
1.2
1.1
u/ml
3.1
6.7
1.23
13
130
(3010503) CD19 cells [#/volume] in Blood
6
27
2.23
0.93
2.0
2.4
e9/l
0.2
0.1
—
6
27
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
10
55
1.82
0.92
4.2
6.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
28
201
1.40
0.92
9.0
3.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
30
2.00
0.87
1.0
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
24
170
1.42
0.85
1.5
1.5
—
—
—
0
0
(44813793)
13
80
1.63
0.84
1.2
1.0
—
—
—
0
0
(4211845)
8
47
1.71
0.80
2.3
2.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
33
1.82
0.79
1.2
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
106
1.52
0.79
1.8
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
33
251
1.32
0.79
1.5
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
9
54
1.67
0.74
1.7
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
9
55
1.64
0.73
1.2
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
9
55
1.64
0.73
2.3
3.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
25
2.00
0.72
2.6
2.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
39
1.80
0.72
1.0
1.0
iu/ml
149.8
201.6
—
7
39
(3006462) Nitrate [Presence] in Urine
7
41
1.71
0.70
2.4
2.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
41
1.71
0.70
1.1
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
69
1.60
0.68
1.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
13
86
1.52
0.66
1.5
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
20
145
1.39
0.66
2.8
2.2
g/l
131.7
133.3
0.13
12
101
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
27
206
1.32
0.65
1.3
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
44
1.59
0.65
1.1
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
37
459
0.80
0.64
1.4
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
22
163
1.36
0.64
1.2
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
49
1.64
0.62
1.1
1.0
miu/ml
2228.1
1372.4
—
8
49
(3011648) Oxygen content in Venous blood
8
51
1.57
0.60
1.6
3.6
%
9.4
11.6
—
8
51
(21494434) Karyotype in Bone marrow
8
51
1.57
0.60
1.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
45
373
1.21
0.58
1.3
1.4
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
6
35
1.72
0.57
3.7
2.6
—
46.6
—
0
6
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
81
1.49
0.57
1.4
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
6
37
1.62
0.55
1.2
1.4
—
—
—
0
0
(4034850)
34
277
1.23
0.53
12.9
7.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
14
100
1.40
0.52
3.5
2.0
u/ml
4.2
4.6
0.18
14
86
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
14
100
1.40
0.52
3.3
4.1
u/ml
34.4
135.8
—
5
32
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
9
65
1.39
0.50
1.4
1.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
26
207
1.26
0.49
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
26
208
1.26
0.48
1.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
44
516
0.85
0.47
1.5
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
47
1.49
0.47
1.0
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
49
565
0.86
0.44
1.4
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
43
500
0.85
0.43
1.5
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
59
668
0.88
0.42
1.5
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
10
70
1.43
0.41
2.8
2.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
43
498
0.86
0.41
1.4
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
15
0.00
0.41
0.0
5.6
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
16
0.00
0.41
0.0
5.8
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
3.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
23
187
1.23
0.39
2.3
2.4
ug/min
199.2
96.3
0.32
15
119
(3039443) Prostate specific Ag panel - Serum or Plasma
8
113
0.71
0.37
2.3
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
110
1191
0.92
0.37
1.5
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
81
1.36
0.36
1.1
2.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
45
512
0.87
0.36
1.6
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
13
99
1.32
0.35
1.1
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
25
210
1.19
0.33
1.5
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
54
1.30
0.30
1.4
1.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
10
75
1.34
0.30
1.0
1.0
—
0.3
—
0
13
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
55
1.27
0.30
1.3
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
22
185
1.19
0.29
1.0
1.0
u/ml
1.4
5.5
—
10
74
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
110
0.73
0.29
1.3
1.3
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
8
62
1.29
0.28
1.9
1.1
—
71.8
—
0
5
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
47
521
0.90
0.27
1.6
1.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
67
1.20
0.26
1.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
73
0.68
0.26
1.2
1.3
—
1.4
—
0
6
(1761868) Lipid panel - Serum or Plasma
399
3883
1.04
0.26
2.6
2.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
73
1.23
0.25
1.6
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
128
1352
0.94
0.25
1.2
1.3
—
—
—
0
0
(4024509)
9
74
1.22
0.25
1.7
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
13
105
1.24
0.25
1.6
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
23
199
1.16
0.23
1.1
1.0
u/ml
2.2
5.2
—
7
71
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
39
1.28
0.23
1.2
1.4
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
11
0.00
0.21
0.0
5.5
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(4281824)
8
103
0.78
0.21
1.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
83
785
1.06
0.18
1.4
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
69
1.16
0.16
1.4
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
19
168
1.13
0.15
1.4
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
78
0.77
0.15
1.7
1.3
g/l
1.1
1.0
—
6
78
(3010726) Horse dander IgE Ab [Units/volume] in Serum
25
226
1.11
0.15
1.1
1.1
u/ml
1.3
5.0
—
5
59
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
9
80
1.13
0.15
7.3
2.8
u/ml
36.8
60.5
—
9
80
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
50
469
1.07
0.14
1.9
2.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
77
806
0.95
0.13
1.5
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
18
162
1.11
0.12
1.1
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
59
619
0.95
0.11
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
59
618
0.95
0.11
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
59
617
0.95
0.10
1.4
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
59
615
0.96
0.09
1.4
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
7
64
1.09
0.08
1.1
1.5
g/l
37.5
33.8
—
7
57
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
67
1.05
0.08
2.3
3.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
20
209
0.96
0.03
4.7
3.0
mg/l
20.9
26.7
0.36
11
134
(40768793) Breast Pathology biopsy report
27
266
1.02
0.00
1.3
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
103
0.97
0.00
1.2
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
6
66
0.91
0.00
1.2
1.5
mmol/l
5.9
5.6
—
6
66
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
114
1140
1.00
0.00
1.8
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
86
0.93
0.00
1.1
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
61
0.98
0.00
1.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
2.5
—
0
5
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
6
0.00
0.00
0.0
6.7
—
6.7
—
0
6
(3041806) Other cells [#/volume] in Blood by Manual count
9
93
0.97
0.00
1.4
1.5
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
20.7
—
0
6
(3014891) Appearance of Pleural fluid
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
58
0.86
0.00
1.2
1.3
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
161.4
—
0
5
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
9.7
—
0
7
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
5
0.00
0.00
0.0
1.2
—
47.9
—
0
5
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
5
0.00
0.00
0.0
1.2
—
40.1
—
0
5
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
16.0
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_HYPERHIDROSIS – Hyperhidrosis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).